Markets

Will AI-designed intrabodies be used in clinical trials for Alzheimer's, Parkinson's, or MND by December 31, 2027?

Yes0%No0%
Loading...

About this market

This market resolves to Yes if any AI-designed intrabodies are used in clinical trials for Alzheimer's, Parkinson's, or Motor Neurone Disease by December 31, 2027. To confirm resolution, announcements from reputable research institutions or clinical trial registries will be used.

Rules

  • Market closes at 12/31/2027.
  • Logic weighted resolution applies.